Synmosa Biopharma Tangible Net Worth Ratio
Synmosa Biopharma tangible net worth ratio. Synmosa Biopharma (4114) has a Tangible Net Worth Ratio of 96.2% as of December 2025. This metric is calculated by deducting intangible assets (NT$383.90 Million) from net assets (NT$10.10 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Synmosa Biopharma (4114) strategic asset index to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Synmosa Biopharma (2015–2025)
Tangible net worth ratio of Synmosa Biopharma from 2015 to 2025. This chart shows how Synmosa Biopharma's Tangible Net Worth Ratio has changed across 11 annual periods from 2015 to 2025. As of December 2025, the ratio stands at 96.2%, reflecting net assets of NT$10.10 Billion with intangible assets of NT$383.90 Million TWD. See Synmosa Biopharma (4114) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Synmosa Biopharma Tangible Net Worth Ratio by Year (2015–2025)
Synmosa Biopharma tangible net worth ratio by year from 2015 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Synmosa Biopharma from 2015 to 2025, covering 11 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 4114 market cap overview.
| Year | Tangible NW Ratio | Net Assets (TWD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 96.2% | NT$10.10 Billion | NT$383.90 Million | NT$13.99 Billion | ▲ +1.5 pp |
| 2024 | 94.7% | NT$8.40 Billion | NT$449.22 Million | NT$12.30 Billion | ▲ +0.8 pp |
| 2023 | 93.9% | NT$8.10 Billion | NT$496.56 Million | NT$11.73 Billion | ▲ +1.3 pp |
| 2022 | 92.5% | NT$6.65 Billion | NT$496.80 Million | NT$11.20 Billion | ▲ +0.6 pp |
| 2021 | 91.9% | NT$6.10 Billion | NT$494.03 Million | NT$10.32 Billion | ▼ -8.1 pp |
| 2020 | 100.0% | NT$5.95 Billion | NT$0.00 | NT$10.38 Billion | ▲ +0.0 pp |
| 2019 | 100.0% | NT$4.81 Billion | NT$0.00 | NT$8.73 Billion | ▲ +6.7 pp |
| 2018 | 93.3% | NT$4.49 Billion | NT$299.46 Million | NT$7.54 Billion | ▲ +0.7 pp |
| 2017 | 92.6% | NT$3.97 Billion | NT$291.70 Million | NT$7.50 Billion | ▼ -3.9 pp |
| 2016 | 96.6% | NT$4.35 Billion | NT$148.97 Million | NT$6.79 Billion | ▲ +2.5 pp |
| 2015 | 94.1% | NT$3.01 Billion | NT$178.14 Million | NT$4.59 Billion | — |